Chuchalin Alexander G, Khaltaev Nikolai, Antonov Nikolay S, Galkin Dmitry V, Manakov Leonid G, Antonini Paola, Murphy Michael, Solodovnikov Alexander G, Bousquet Jean, Pereira Marcelo H S, Demko Irina V
Institute of Pulmonology, Federal Medical and Biological Agency, Moscow, Russia.
Global Alliance Against Chronic Respiratory Diseases (GARD), Genève, Switzerland.
Int J Chron Obstruct Pulmon Dis. 2014 Sep 12;9:963-74. doi: 10.2147/COPD.S67283. eCollection 2014.
Estimation suggests that at least 4 million people die, annually, as a result of chronic respiratory disease (CRD). The Global Alliance against Chronic Respiratory Diseases (GARD) was formed following a mandate from the World Health Assembly to address this serious and growing health problem.
To investigate the prevalence of CRD in Russian symptomatic patients and to evaluate the frequency of major risk factors for CRD in Russia.
A cross-sectional, population-based epidemiological study using the GARD questionnaire on adults from 12 regions of the Russian Federation. Common respiratory symptoms and risk factors were recorded. Spirometry was performed in respondents with suspected CRD. Allergic rhinitis (AR) and chronic bronchitis (CB) were defined by the presence of related symptoms according to the Allergic Rhinitis and its Impact on Asthma and the Global Initiative for Obstructive Lung Disease guidelines; asthma was defined based on disease symptoms; chronic obstructive pulmonary disease (COPD) was defined as a post-bronchodilator forced expiratory volume per 1 second/forced vital capacity ratio <0.7 in symptomatic patients, following the Global Initiative for Obstructive Lung Disease guidelines.
The number of questionnaires completed was 7,164 (mean age 43.4 years; 57.2% female). The prevalence of asthma symptoms was 25.7%, AR 18.2%, and CB 8.6%. Based on patient self-reported diagnosis, 6.9% had asthma, 6.5% AR, and 22.2% CB. The prevalence of COPD based on spirometry in patients with respiratory symptoms was estimated as 21.8%.
The prevalence of respiratory diseases and risk factors was high in Russia when compared to available data. For bronchial asthma and AR, the prevalence for related symptoms was higher than self-reported previous diagnosis.
据估计,每年至少有400万人死于慢性呼吸道疾病(CRD)。全球抗击慢性呼吸道疾病联盟(GARD)是根据世界卫生大会的授权成立的,旨在应对这一严重且日益严重的健康问题。
调查俄罗斯有症状患者中CRD的患病率,并评估俄罗斯CRD主要危险因素的频率。
一项基于人群的横断面流行病学研究,使用GARD问卷对俄罗斯联邦12个地区的成年人进行调查。记录常见的呼吸道症状和危险因素。对疑似CRD的受访者进行肺功能测定。变应性鼻炎(AR)和慢性支气管炎(CB)根据《变应性鼻炎及其对哮喘的影响》和《慢性阻塞性肺疾病全球倡议》指南中相关症状的存在来定义;哮喘根据疾病症状来定义;慢性阻塞性肺疾病(COPD)根据《慢性阻塞性肺疾病全球倡议》指南,在有症状的患者中,定义为支气管扩张剂后1秒用力呼气量/用力肺活量比值<0.7。
完成的问卷数量为7164份(平均年龄43.4岁;女性占57.2%)。哮喘症状的患病率为25.7%,AR为18.2%,CB为8.6%。根据患者自我报告的诊断,6.9%患有哮喘,6.5%患有AR,22.2%患有CB。根据肺功能测定,有呼吸道症状患者中COPD的患病率估计为21.8%。
与现有数据相比,俄罗斯呼吸道疾病和危险因素的患病率较高。对于支气管哮喘和AR,相关症状的患病率高于自我报告的既往诊断。